Table 1.
Baseline characteristics.
| Characteristic | Values |
|---|---|
| Demographic characteristics | |
| Age, years | 65.5 ± 9.8 |
| Male sex, n (%) | 12 (48) |
| Height, cm | 165.8 ± 8.2 |
| Body mass index (kg/m2) | 29.5 ± 4.1 |
|
| |
| Disease characteristics, n (%) | |
| Hypertension | 17 (68) |
| Coronary artery disease | 4 (16) |
| Dyslipidemia | 23 (92) |
| Atrial fibrillation | 10 (40) |
| Chronic kidney disease (eGFR 30–60 ml/m2/1.73 m2) | 3 (12) |
|
| |
| Pacemaker characteristics | |
| Atrial pacing (%) | 85.0 (64.0–93.0) |
| Ventricular pacing < 1%, n (%) | 14 (56) |
|
| |
| Cardiovascular medication, n (%) | |
| Treatment-naïve | 6 (28) |
| ACE inhibitors/ARBs | 8 (32) |
| Calcium channel blockers | 4 (16) |
| Diuretics | 5 (20) |
| ß-Blockers | 12 (48) |
| Statins | 4 (16) |
| Antiplatelets | 8 (32) |
| Anticoagulants | 2 (8) |
|
| |
| Blood analyses | |
| Glucose (mmol/L) | 5.4 ± 0.7 |
| Total cholesterol (mmol/L) | 5.8 ± 1.2 |
| LDL cholesterol (mmol/L) | 3.9 ± 1.2 |
| HDL cholesterol (mmol/L) | 1.6 ± 0.5 |
| Triglycerides (mmol/L) | 1.5 ± 0.5 |
| eGFR (mL/min/1.73 m2) | 78.5 ± 16.2 |
| NT-proBNP (pg/mL) | 148.0 (85.0–186.0) |
| hsCRP (mg/L) | 1.6 (1.0–2.6) |
|
| |
| Hemodynamic characteristics | |
| Peripheral systolic BP (mmHg) | 127.8 ± 14.9 |
| Peripheral diastolic BP (mmHg) | 80.8 ± 10.0 |
| Heart rate (bpm) | 64.4 ± 3.9 |
|
| |
| Others | |
| Current smoking, n (%) | 5 (20) |
Values are presented as mean ± SD, median (interquartile range), or count (%). eGFR indicates estimated glomerular filtration rate; ACE, angiotensin-converting enzyme; ARB, angiotensin receptor blocker; LDL, low-density lipoprotein; HDL, high-density lipoprotein; NT-proBNP, N-terminal pro-brain natriuretic peptide; hsCRP, high-sensitivity C-reactive protein; and BP, blood pressure.